Metoclopramide has no effect on abdominal activity of sestamibi in myocardial spet

Nuclear Medicine Communications

Volumn 20, Issue 7, 1999, Pages 623-626

  Weinmann, P ^a   Moretti, J L ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METOCLOPRAMIDE;

ADULT; AGED; ARTICLE; ARTIFACT REDUCTION; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEART SCINTISCANNING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE ABSORPTION; LIVER CLEARANCE; MALE; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ABDOMEN; ARTIFACTS; DOPAMINE ANTAGONISTS; EXERCISE TEST; FEMALE; HEART; HUMANS; MALE; METOCLOPRAMIDE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032810402     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199907000-00005     Document Type: Article

References (5)

1. m-MIBI cardiac SPECT interpretation. Nucl Med Commun 1996; 17: 851-856.
2. Hillier DA, Wallis JW, Miller TR. Cardiac artifacts due to hepatobiliary uptake in Tc-99m myocardial SPECT (abstract). J Nucl Med 1997; 38 (suppl.): 75p.
3. Pinkert J, Kutzner H, Lindner C, Lopez J, Kropp J, Franke WG. Reduction of artifacts related to intestinal activity in myocardial perfusion SPECT with sestamibi (abstract). J Nucl Med 1997; 38 (supp l.): 75p.
4. Harrington RA, Hamilton CW, Brodgen RN, Linkewich JA, Romankiewicz JA, Heel RC. Metoclopramide: An updated review of its pharmacological properties and clinical use. Drugs 1983; 25: 451-494.
5. Weinmann P, Foult JM, Le Guludec D et al. Dual-isotope myocardial imaging: Feasibility, advantages and limitations. Eur J Nucl Med 1994; 21: 212-215.